spirogermanium has been researched along with Carcinoma, Squamous Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellamy, AS; Hill, BT; Jenkins, LY; Whatley, SA; Whelan, RD | 1 |
| Budman, DR; Degnan, TJ; Pasmantier, M; Schulman, P; Vinciguerra, V; Weiselberg, L | 1 |
| Chiuten, DF; Dhingra, HM; Holoye, PY; Murphy, WK; Spitzer, G; Umsawasdi, T; Valdivieso, M | 1 |
| Brenner, DE; Burnett, LS; Dillon, M; Forastiere, A; Greco, FA; Jones, HW; Rosenshein, NB; Tipping, S; Wiernik, PH | 1 |
4 other study(ies) available for spirogermanium and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitro.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Line; Cell Survival; Cells, Cultured; Colonic Neoplasms; Cricetinae; Female; Germanium; Humans; Mesocricetus; Neuroblastoma; Neurons; Organometallic Compounds; Ovary; Rats; Spiro Compounds | 1982 |
Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Germanium; Humans; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Ovarian Neoplasms; Spiro Compounds | 1982 |
Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Germanium; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Spiro Compounds | 1986 |
Phase II study of spirogermanium in patients with advanced carcinoma of the cervix.
Topics: Adult; Carcinoma, Squamous Cell; Drug Evaluation; Female; Germanium; Humans; Infusions, Parenteral; Middle Aged; Organometallic Compounds; Prognosis; Spiro Compounds; Uterine Cervical Neoplasms | 1985 |